| Date | Time | Source | Headline | Symbol | Company |
| 02/16/2017 | 9:15AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/16/2017 | 8:52AM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/14/2017 | 10:48AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/13/2017 | 4:16PM | Edgar (US Regulatory) | Amended Quarterly Report (10-q/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/10/2017 | 10:52AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/09/2017 | 1:09PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/09/2017 | 9:53AM | Edgar (US Regulatory) | Schedule 13g | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/08/2017 | 5:14PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/07/2017 | 5:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/07/2017 | 5:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/07/2017 | 5:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/07/2017 | 4:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/07/2017 | 4:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/07/2017 | 4:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/07/2017 | 4:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/07/2017 | 4:51PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/06/2017 | 4:06PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/06/2017 | 7:35AM | Business Wire | ARIAD Announces Submission of Marketing Authorization Application for Brigatinib to the European Medicines Agency | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/02/2017 | 4:44PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/02/2017 | 4:43PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/02/2017 | 9:41AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/02/2017 | 6:10AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/01/2017 | 4:58PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/01/2017 | 4:57PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/01/2017 | 4:57PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/01/2017 | 4:56PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 02/01/2017 | 4:55PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 01/30/2017 | 5:24PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 01/30/2017 | 5:22PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 01/24/2017 | 5:23PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |